Comprehensive evaluation of different solidaginis herba extracts

被引：6

作者：

Apáti, P ^{[1
]}

Kristó, TS ^{[1
]}

Szoke, É ^{[1
]}

Kéry, A ^{[1
]}

Szentmihályi, K ^{[1
]}

Vinkler, P ^{[1
]}

机构：

[1] Semmelweis Univ, Dept Pharmacognosy, H-1085 Budapest, Hungary

来源：

PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MEDICINAL AND AROMATIC PLANTS, PT II: (FOLLOW UP OF ACTA HORTICULTURAE 576) | 2003年 / 597期

关键词：

flavonoids; HPLC; ICP-OES; mineral elements; Solidago x canadensis;

D O I：

10.17660/ActaHortic.2003.597.7

中图分类号：

S3 [农学（农艺学）];

学科分类号：

0901 ;

摘要：

Canadian golden rod (Solidago x canadensis L., Asteraceae) has been used in European phytotheraphy for 700 years as a urological and antiphlogistical remedy. Dissolution rates of quercetin glycosides; and organic acids have been studied, as well as mineral elements of Solidaginis herba into different tinctures and aqueous extracts. Determination of the flavonoids in Solidaginis herba (16.75 mg/g) and of flavonoid release in extracts (14.9-72.9 %) was carried out by spectrophotometric analysis. To study the flavonoid composition of the crude drug, an HPLC technique was applied. The concentrations of 16 mineral elements (Al, B, Ba, Ca, Co, Cr, Cu, Fe, K, Mg, Mn, Na, P, S, Ti, Zn) in the samples were measured by inductively coupled plasma atomic emission spectrometry (ICP-OES). Connection has been found between some ion concentrations and the presence and quantity of flavonoids.

引用

页码：69 / 73

页数：5

共 13 条

[1]

Bader G., 1999, Zeitschrift fur Phytotherapie, V20, P196

[2] Phytotherapeutic agents in the treatment of lower urinary tract symptoms: A demographic analysis of awareness and use at the University of Chicago [J].

Bales, GT ;

Christiano, AP ;

Kirsh, EJ ;

Gerber, GS .

UROLOGY, 1999, 54 (01) :86-89

[3]

Budzianowsld J., 1990, SCI PHARM, V58, P15

[4] CHROMATOGRAPHIC BEHAVIOR OF FLAVONOID COMPOUNDS IN REVERSED-PHASE HPLC SYSTEMS [J].

DONDI, F ;

BLO, G ;

KAHIE, YD ;

LODI, G ;

PIETROGRANDE, C ;

RESCHIGLIAN, P .

CHROMATOGRAPHIA, 1988, 25 (05) :423-429

[5]

HANSEL R, 1994, HAGERS HDB PHARM PRA, V6, P752

[6]

Meier B., 1991, Planta Medica, V57, pA26, DOI 10.1055/s-2006-960273

[7]

Melzig M. F., 2000, Zeitschrift fur Phytotherapie, V21, P193

[8]

Schiller H., 1989, Z PHYT, V10, P77

[9]

SCHNEIDERLEUKEL K, 1994, Z PHYTOTHER, V15, P215

[10]

Szentmihalyi K, 1998, PHYTOTHER RES, V12, P163, DOI 10.1002/(SICI)1099-1573(199805)12:3&lt

← 1 2 →